Keyphrases
Cholangiocarcinoma
100%
Sorafenib
50%
Gene Therapy
50%
Epigenome
50%
Tumor Selectivity
50%
Dysregulation
50%
Organic Cation Transporter
50%
DNA Methylation (DNAm)
30%
Histone Post-translational Modifications
25%
Non-coding RNA (ncRNA)
25%
Oncogenesis
25%
Epigenetic Landscape
25%
Chromatin Remodelers
25%
Epigenomics
25%
Solid Tumors
25%
Disease Progression
25%
Cholangiocytes
25%
Molecular Alterations
25%
Epigenetic Marks
25%
Genomic Instability
25%
Obeticholic Acid
15%
INT-777
15%
Mitochondrial Energy Metabolism
15%
SLC22A1
15%
Immunology and Microbiology
Cholangiocyte
100%
DNA Methylation
55%
Histone
55%
Post-Translational Modification
50%
Sensitization
50%
Genomic Instability
50%
Energy Metabolism
50%
Sorafenib
50%
Epigenetics
50%
Chromatin Assembly and Disassembly
50%
Cell Migration
33%
Cell Proliferation
33%
Inflammation Response
16%
Liver Tissue
16%
Cell Line
16%
Agonist
16%
Normal Human
16%
Tumor Volume
16%
Magnetic Resonance Imaging
16%
Medicine and Dentistry
Cholangiocarcinoma
100%
Neoplasm
57%
Gene Therapy
50%
Sensitization
50%
Sorafenib
50%
Cancer
30%
